Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission-Reference-Cited by-同舟云学术

Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission

Published:2017-07-24 Issue:1 Volume:179 Page:120-130
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Han Li-Jie¹^ORCID,Wang Yu²,Fan Zhi-Ping¹,Huang Fen¹,Zhou Jian³,Fu Yue-Wen³,Qu Hong⁴,Xuan Li¹,Xu Na¹,Ye Jie-Yu¹,Bian Zhi-Lei²,Song Yong-Ping³,Huang Xiao-Jun²^ORCID,Liu Qi-Fa¹

Affiliation:

1. Department of Haematology; Nanfang Hospital; Southern Medical University; Guangzhou China

2. Peking University People's Hospital; Peking University Institute of Haematology; Beijing China

3. Henan Cancer Hospital; The Affiliated Cancer Hospital of Zhengzhou University; Zhengzhou China

4. Panyu Central Hospital; Guangzhou China

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Project of Health Collaborative Innovation of Guangzhou City

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14854/fullpdf

Reference40 articles.

1. Acute lymphoblastic leukemia, version 2.2015;Alvarnas;Journal of the National Comprehensive Cancer Network,2015

2. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation;Bashey;Journal of Clinical Oncology,2013

3. Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation;Chang;Journal of Clinical Oncology,2016a

4. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?;Chang;Journal of Hematology & Oncology,2016b

5. Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation;Chen;OncoTargets and Therapy,2015

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Cutaneous graft-versus-host disease;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Introduction on Stem Cell Therapy and Regeneration;Comprehensive Hematology and Stem Cell Research;2024

4. PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2023-12-05

5. Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease;British Journal of Haematology;2023-05-08